PhaseBio Pharmaceuticals (PHAS): 100% Lucrative Buy?
PhaseBio Pharmaceuticals (PHAS) is trading higher based on a new recent co-development collaboration with SFJ Pharmaceuticals for PB2452. PhaseBio Pharmaceuticals is a clinical stage biopharmaceutical